Divergent Immune Pathways in Coronary Artery Disease and Aortic Stenosis: The Role of Chronic Inflammation and Senescence
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115248 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von José Joaquín Domínguez-Del-Castillo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Pathology Group (GA09), Maimonides Biomedical Research Institute, University of Cordoba, Reina Sofia University Hospital, Avda Menedez…. Hauptthemen laut MEDLINE: Coronary Artery Disease, Inflammation, Aortic Valve Stenosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Junta de Andalucía, Fundacion para la investigacion biomedica de Cordoba.
Abstract (Originalsprache)
Coronary artery disease (CAD) remains a major cause of cardiovascular morbidity and mortality, with growing evidence linking immune dysregulation to its pathogenesis. Aortic stenosis often coexists with CAD (ASCAD), representing an advanced disease form. This study investigates immune pathways in isolated CAD (iCAD) and ASCAD. For this purpose, peripheral blood from 72 individuals (healthy donors, iCAD, and ASCAD patients) was analysed via flow cytometry to assess immune populations. Circulating cytokine levels were measured, and machine learning models identified predictive immune biomarkers. Our data showed that both iCAD and ASCAD patients exhibited immune dysregulation, with reduced dendritic cells, basophils, NK cells, B cells, and T cells, alongside lower frequencies of DCs, lymphocytes, CD8+CD28+ T cells, and CD57+ T cells. Elevated IL-15 and fractalkine, but reduced IL-8 and MCP-1, suggest impaired monocyte and neutrophil mobilisation due to immune cell sequestration in vascular lesions. Distinct immune features emerged between iCAD and ASCAD. iCAD patients showed heightened immune activation, with increased inflammatory CD14+CD16+ monocytes, higher Treg frequencies, and greater CD4+ T cell differentiation into TEM and TEMRA phenotypes. In contrast, ASCAD patients exhibited pronounced immunosenescence, with higher neutrophil counts, lymphopenia, and increased NK and T cell cytotoxicity. Our predictive model distinguished iCAD from ASCAD with high accuracy, identifying CD4+ T cell memory subsets and CD57 expression as key discriminators. This study reveals iCAD as being driven by immune activation and ASCAD by immunosenescence and cytotoxicity. These insights advance CAD immunopathology understanding and support immune-based classification, particularly for ASCAD, where treatment remains limited to surgical intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Pathology Group (GA09), Maimonides Biomedical Research Institute, University of Cordoba, Reina Sofia University Hospital, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
- Department of Cell Biology, Physiology and Immunology, University of Cordoba, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
- Immunology and Allergy Group (GC01), Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba, Reina Sofia University Hospital, Avda Menedez Pidal s/n, 14004 Cordoba, Spain.
- Hospital Nostra Senyora de Meritxell, Avinguda Fiter i Rossell 13, AD700 Escaldes-Engordany, Andorra.
- Immunology Unit, Department of Physiology, University of Extremadura, 10003 Cáceres, Spain.
ORCID-Profile: José Joaquín Domínguez-Del-Castillo, Pablo Álvarez-Heredia, Maria-Isabel Vallejo-Bermúdez, Raquel Tarazona, Rafael Solana, Ignacio Muñoz, Alejandra Pera
Förderung
- Instituto de Salud Carlos III
- Junta de Andalucía
- Fundacion para la investigacion biomedica de Cordoba
- European Union
- Consejería de salud y familias Junta de Andalucía
- Fundación para la Investigación Biomédica de Córdoba
Zitieren
APA
Domínguez-Del-Castillo, J. J., Álvarez-Heredia, P., Reina-Alfonso, I., Vallejo-Bermúdez, M. I., López-Romero, R., Moreno-Moreno, J. A., Bilbao-Carrasco, L., Moya-Gonzalez, J., Muñoz-Calero, M., Tarazona, R., Solana, R., Batista-Duharte, A., Muñoz, I., & Pera, A. (2025). Divergent Immune Pathways in Coronary Artery Disease and Aortic Stenosis: The Role of Chronic Inflammation and Senescence. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115248
Vancouver
Domínguez-Del-Castillo JJ, Álvarez-Heredia P, Reina-Alfonso I, Vallejo-Bermúdez MI, López-Romero R, Moreno-Moreno JA, et al. Divergent Immune Pathways in Coronary Artery Disease and Aortic Stenosis: The Role of Chronic Inflammation and Senescence. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115248
BibTeX
@article{DomnguezDelCastillo2025,
author = {Domínguez-Del-Castillo, José Joaquín and Álvarez-Heredia, Pablo and Reina-Alfonso, Irene and Vallejo-Bermúdez, Maria-Isabel and López-Romero, Rosalía and Moreno-Moreno, Jose Antonio and Bilbao-Carrasco, Lucía and Moya-Gonzalez, Javier and Muñoz-Calero, María and Tarazona, Raquel and Solana, Rafael and Batista-Duharte, Alexander and Muñoz, Ignacio and Pera, Alejandra},
title = {Divergent Immune Pathways in Coronary Artery Disease and Aortic Stenosis: The Role of Chronic Inflammation and Senescence},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115248}
}
EUVIMED